###begin article-title 0
Dynamic Pax6 expression during the neurogenic cell cycle influences proliferation and cell fate choices of retinal progenitors
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 337 344 <span type="species:ncbi:9031">chicken</span>
The paired homeobox protein Pax6 is essential for proliferation and pluripotency of retinal progenitors. However, temporal changes in Pax6 protein expression associated with the generation of various retinal neurons have not been characterized with regard to the cell cycle. Here, we examine the dynamic changes of Pax6 expression among chicken retinal progenitors as they progress through the neurogenic cell cycle, and determine the effects of altered Pax6 levels on retinogenesis.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
We provide evidence that during the preneurogenic to neurogenic transition, Pax6 protein levels in proliferating progenitor cells are down-regulated. Neurogenic retinal progenitors retain a relatively low level of Pax6 protein, whereas postmitotic neurons either elevate or extinguish Pax6 expression in a cell type-specific manner. Cell imaging and cell cycle analyses show that neurogenic progenitors in the S phase of the cell cycle contain low levels of Pax6 protein, whereas a subset of progenitors exhibits divergent levels of Pax6 protein upon entering the G2 phase of the cell cycle. We also show that M phase cells contain varied levels of Pax6, and some correlate with the onset of early neuronal marker expression, forecasting cell cycle exit and cell fate commitment. Furthermore, either elevating or knocking down Pax6 attenuates cell proliferation and results in increased cell death. Reducing Pax6 decreases retinal ganglion cell genesis and enhances cone photoreceptor and amacrine interneuron production, whereas elevating Pax6 suppresses cone photoreceptor and amacrine cell fates.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
These studies demonstrate for the first time quantitative changes in Pax6 protein expression during the preneurogenic to neurogenic transition and during the neurogenic cell cycle. The results indicate that Pax6 protein levels are stringently controlled in proliferating progenitors. Maintaining a relatively low Pax6 protein level is necessary for S phase re-entry, whereas rapid accumulation or reduction of Pax6 protein during the G2/M phase of the cell cycle may be required for specific neuronal fates. These findings thus provide novel insights on the dynamic regulation of Pax6 protein among neurogenic progenitors and the temporal frame of neuronal fate determination.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 146 157 146 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
The Pax6 gene encodes an evolutionarily conserved paired homeobox protein critically involved in eye development and retinogenesis [1-5]. In both Drosophila and vertebrates, ectopic expression of Pax6 induces ectopic eyes or lens [2,6,7], indicating an instructive role of Pax6 in ocular tissue determination. Genetic studies have demonstrated that the dosages of Pax6 strongly impact the formation and growth of ocular tissues. Homozygous or heterozygous loss of function Pax6 mutants have either no eye or small eye phenotypes [8-11]. Conversely, increasing dosages of the Pax6 gene also lead to microphthalmia and malformed retinas [12,13]. Furthermore, Pax6 is involved in pattern formation of the vertebrate eye. Aberrant Pax6 expression results in malformation of the anterior segment of the eye [5,14-16]. Pax6 expression in the optic vesicle is required for establishing the naso-temporal axis and the dorsal characteristics of the retina [17], whereas Pax6 expressed in the distal optic cup reciprocally suppresses Pax2 in the optic stalk to establish the optic cup/stalk boundary [18]. The complex roles of Pax6 in eye development are reflected by the existence of multiple enhancers that regulate the exquisite spatial and temporal expression of Pax6 transcripts in neural and non-neural ocular tissues [17,19-21].
###end p 9
###begin p 10
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 355 366 355 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 390 398 390 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eyeless </italic>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eyegone </italic>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 674 679 <span type="species:ncbi:10090">mouse</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
Multiple Pax6 isoforms are encoded by the Pax6 gene in vertebrates [22-24]. The canonical Pax6 and the Pax6(5a) isoform, which contains amino acid residues encoded by an alternatively spliced exon inserted within the paired domain, are commonly found among various vertebrates [22,23,25]. The mammalian Pax6 and Pax6(5a) isoforms, and their corresponding Drosophila homologs encoded by the eyeless and eyegone genes, exhibit distinct biological activities. Both Pax6 and eyeless can induce ectopic eye formation in the fly wing imaginal disc [2], whereas Pax6(5a) and eyegone can elicit only cell proliferation but not neuronal differentiation [26]. Similarly, in embryonic mouse cortex, Pax6 influences both cell proliferation and neuronal differentiation, but Pax6(5a) only affects proliferation [27,28]. In mice missing the transcript Pax6(5a), lens abnormalities and iris hypoplasia are observed, but development of the neural retina remains largely normal [29], suggesting that Pax6 is able to compensate for the function of Pax6(5a) in the neural retina.
###end p 10
###begin p 11
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 729 734 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ngn2 </italic>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
During mammalian central nervous system development, multipotent progenitors undergo a transition from the preneurogenic stage, when symmetrical divisions occur and give rise to proliferative progeny, to the neurogenic stage, during which a subset of progenitors withdraw from the cell cycle and initiate neuronal differentiation. In the cortex, reducing Pax6 expression levels affects the length of the cell cycle and the progression from symmetrical to asymmetrical division among cortical progenitors [30]. Furthermore, decreased Pax6 expression leads to depletion of basal cortical progenitor and precocious neuronal differentiation [31]. In the spinal cord, altering Pax6 levels affects the expression of the proneural gene Ngn2 and the timing of cell cycle exit [32].
###end p 11
###begin p 12
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 590 592 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 857 859 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1013 1017 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crx </italic>
###xml 1144 1146 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
In the vertebrate retina, multipotent progenitor cells give rise to six major types of neurons and one type of glial cell in a conserved temporal order [33-38]. At the onset of retinogenesis, the central retinal progenitors enter the neurogenic stage first, while the peripheral retina remains in a preneural state [39]. When Pax6 is conditionally ablated in the peripheral retina by using the Pax6 alpha cre mouse, which encodes the Pax6 P0 promoter and the alpha enhancer driving the expression of cre recombinase, progenitor expansion is affected, resulting in a retina reduced in size [40]. In addition, in the Pax6 alpha cre-mediated Pax6 conditional knockout mutant, peripheral retinal progenitors are unable to express multiple neurogenic basic helix-loop-helix (bHLH) transcriptional factors and are limited to producing only amacrine interneurons [40]. Recently, it has been reported that Pax6 alpha cre-mediated Pax6 deletion in the peripheral retina unmasks a suppression of the cone-rod homeobox gene Crx by Pax6, and more centrally localized Pax6 deletion by the Chx10-cre driver also leads to the loss of progenitor multipotency [41]. Thus, Pax6 differentially expressed by the central or peripheral retinal progenitor pools may serve distinct functions during development, but nonetheless is required for generation of multiple retinal neurons.
###end p 12
###begin p 13
###xml 297 304 <span type="species:ncbi:9031">chicken</span>
In the mature retina, various neuronal cell types express disparate levels of Pax6. How this highly differential Pax6 expression is achieved among specific neurons remains unclear. In this study, we have analyzed Pax6 expression at the cellular level among neurogenic progenitors in the embryonic chicken retina. We demonstrate a significant down-regulation of Pax6 protein as progenitors undergo the preneurogenic to neurogenic transition. In addition, we show that while neurogenic progenitors maintain a uniformly low Pax6 level during the S phase, a subset of retinal progenitors rapidly increase or decrease their Pax6 levels as they enter G2/M phase of the cell cycle. The divergence of Pax6 protein levels correlate with the onset of differentiation for certain neurons. Moreover, disruption of Pax6 levels among neurogenic progenitor cells leads to aberrant proliferation and production of neuronal cell types. These results reveal for the first time the dynamic expression of Pax6 during the neurogenic cell cycle and highlight the importance of Pax6 protein regulation as neural progenitors adapt to different cell fates.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Dynamic Pax6 expression during retinogenesis
###end title 15
###begin p 16
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A&#8211;C</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 1032 1034 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 28 35 <span type="species:ncbi:9031">chicken</span>
Pax6 mRNA expression in the chicken optic primordium initially begins at Hamburger and Hamilton (HH) stage 8.5 and persists at high levels throughout optic vesicle formation and optic cup morphogenesis [42]. At the onset of retinal neurogenesis at HH stage 17 [43], the expression of Pax6 protein in the central retina begins to decrease among progenitor cells. By HH stage 20, the central retina undergoing active neurogenesis showed significantly lower levels of Pax6 compared to the peripheral retina, and this change in the levels of Pax6 correlated with the propagation of the neurogenic wave, as demarcated by the emergence of NF145-positive neurons (Figure 1A-C). At the peak of retinal ganglion cell (RGC) genesis at embryonic day (E)6.5 (HH stage 30), the ventricular zone occupied by proliferative progenitor cells contained low levels of Pax6, whereas postmitotic RGCs exhibited a high level of Pax6 expression (Figure 1D). The subsequently produced amacrine cells also showed high Pax6 levels at E7 (HH stage 32; Figure 1E). By E12 (HH stage 38), when retinogenesis was near completion, amacrine cells, RGCs and horizontal cells displayed distinct levels of Pax6, in contrast to the absence of Pax6 from the photoreceptor cells and the bipolar cells (Figure 1F).
###end p 16
###begin p 17
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression patterns of Pax6 in the developing chicken retina</bold>
###xml 62 68 62 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-G) </bold>
###xml 493 495 493 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ac</italic>
###xml 513 515 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bc</italic>
###xml 532 533 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 551 554 551 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gcl</italic>
###xml 577 579 577 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hc</italic>
###xml 599 602 599 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">inl</italic>
###xml 625 628 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ipl</italic>
###xml 653 656 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">onl</italic>
###xml 679 680 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 701 704 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ret</italic>
###xml 714 717 714 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpe</italic>
###xml 747 749 747 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vz</italic>
###xml 1417 1419 1414 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 46 53 <span type="species:ncbi:9031">chicken</span>
Expression patterns of Pax6 in the developing chicken retina. (A-G) Expression of Pax6 protein during the preneurogenic to neurogenic transition (A-C, G) and subsequent neurogenesis (D-F). (A-C) Immunofluorescent images of E4.5 (HH stage 24) retinas labeled for Pax6 (A), NF145 (B), and the merge of the two (C). White arrowheads in (B, C) indicate the neurogenic wave front. (D-F) Immunohistochemical images of E6.5 (HH stage 30) (D), E7 (HH stage 32) (E), and E12 (HH stage 38) (F) retinas. ac, amacrine cells; bc, bipolar cells; c, central retina; gcl, ganglion cell layer; hc, horizontal cells; inl, inner nuclear layer; ipl, inner plexiform layer; onl, outer nuclear layer; p, peripheral retina; ret, retina; rpe, retinal pigment epithelium; vz, ventricular zone. Scale bars: 100 mum; scale bar in (A) applies to (A-C), and in (D) to (D-F). (G) Quantification of Pax6 protein levels in the preneurogenic and neurogenic regions. E4.5 (HH stage 25) eyes were cut at the equator to separate the central and peripheral portions. Dissociated retinal cells from the two portions were subjected to flow cytometric analyses to quantify Pax6 protein on a per cell basis. A representative cell distribution profile with regard to Pax6 levels is shown on the left. Average Pax6 levels for the central and peripheral retinal cells (N = 3, mean +/- standard error) are shown on the right. Green, central; red, peripheral. ***P < 0.001.
###end p 17
###begin p 18
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 955 957 955 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi</sup>
###xml 974 976 974 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo</sup>
###xml 996 999 996 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg</sup>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1040 1043 1040 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 1051 1055 1051 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1151 1152 1151 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1163 1166 1163 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1320 1322 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1358 1361 1358 1361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 1638 1641 1638 1641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 1663 1665 1663 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1712 1714 1712 1714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1787 1789 1787 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1812 1815 1812 1815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 1861 1864 1861 1864 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 1960 1970 1960 1970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D,D',D",H</xref>
###xml 2001 2005 2001 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E,I</xref>
###xml 2054 2058 2050 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F,J</xref>
###xml 2078 2082 2074 2078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 2169 2173 2165 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G,K</xref>
###xml 2200 2202 2196 2198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2210 2215 2206 2211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D",H</xref>
To further characterize Pax6 protein levels in retinal progenitor cells and postmitotic neurons, we performed immunolabeling and flow cytometric analyses. Quantification revealed that average Pax6 signal intensity of cells residing in the peripheral halves of the retina was 1.7-fold of that found in the neurogenic central retina at HH stage 25 (Figure 1G). Quantitative measurements of Pax6 between HH stages 30 and 32 showed that the total retinal cell population existed as three distinct populations based on their Pax6 protein levels (Figure 2C, left panel). Similarly, cell distribution based on DNA content measurements also revealed three cell populations with distinct levels of Pax6 among G0/G1 cells with 2n DNA contents (Figure 2C, right panel). Based on cell density profiles of G0/G1 cells with distinct Pax6 signal levels, we delineated the boundaries between the three cell populations and designated these populations as: high Pax6 (Pax6Hi), low Pax6 (Pax6Lo), and no Pax6 (Pax6Neg) cells (Figure 2C). The majority of Pax6Hi and Pax6Neg cells had 2n DNA content and, therefore, were either G0 or G1 cells (Figure 2C; Additional file 1). The Pax6Lo cells represented the largest population of cells (46.5% of total cells) at this stage (Figure 2C) and were distributed throughout the cell cycle (Figure 2C, right panel), indicating that Pax6Lo cells were the proliferating progenitor cells. Immunolabeling of retinal sections showed that progenitor cell marker proliferating cell nuclear antigen (PCNA)-labeled cells were absent from the ganglion cell layer and exclusively distributed in the ventricular zone, where Pax6Lo cells resided (Figure 2A). In addition, flow cytometry showed that PCNA+ progenitor cells were also distributed throughout the cell cycle (Figure 2B), supporting that Pax6Lo cells were progenitor cells. In contrast, Pax6Hi cells were mostly co-labeled with cells positive for the neuronal markers NF145 or NF68 (Figure 2D,D',D",H) the RGC marker Brn3a (Figure 2E,I), and the amacrine cell marker AP2alpha (Figure 2F,J), whereas most Pax6Neg cells were positively labeled with the early cone photoreceptor marker Visinin (Figure 2G,K) and a small subset was NF+ (Figure 2D",H).
###end p 18
###begin p 19
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distinct Pax6 expression levels among progenitors and postmitotic neurons</bold>
###xml 146 150 146 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 241 245 241 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 507 509 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 588 592 588 592 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 748 751 748 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 784 788 784 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 813 819 813 819 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D-G) </bold>
###xml 948 957 944 953 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D', D") </bold>
###xml 1140 1146 1136 1142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H-K) </bold>
###xml 1433 1436 1425 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gcl</italic>
###xml 1459 1461 1451 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1484 1486 1476 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vz</italic>
Distinct Pax6 expression levels among progenitors and postmitotic neurons. Immunocytochemical and flow cytometric analyses of neurogenic retinas. (A) Merged confocal image of PCNA (red) and Pax6 (green) co-labeled E6.5 (HH stage 30) retina. (B) Flow cytometry profile of E6 retinal cells based on PCNA signal and DNA content. The positions of 2n and 4n DNA contents indicate cells residing in the G1/G0 (2n) or G2/M (4n) phase. S phase cells are positioned between 2n and 4n along the DNA content axis. PCNA+ cells (boxed, 83.2% of total cells) are distributed throughout the cell cycle. (C) Flow cytometry profiles for Pax6 levels of total cells (left panel) and Pax6 versus DNA content (right panel) at E7 (HH stage 32). Blue lines delineate Pax6Hi (20.9%), Pax6Lo (46.5%), and Pax6Neg (32.6%) cell popuations. (D-G) Merged confocal images of E6.5 (HH stage 30) retinas co-labeled for Pax6 and NF145 (D), Brn3a (E), AP2alpha (F), or Visinin (G). (D', D") Higher magnification images of NF145 and Pax6 co-labeling near the ventricular surface. Arrows indicate co-labeled cells. Arrowheads point to marker-positive but Pax6-negative cells. (H-K) Flow cytometry profiles of Pax6 and NF68 (H), Brn3a (I), AP2alpha (J), and Visinin (K) at E7 (HH stage 32). Boxed regions delineate distribution of neuronal marker-positive cells according to Pax6 levels. Percentages of marker-positive cells among total cells are shown above the boxes. gcl, ganglion cell layer; vs, ventricular surface; vz, ventricular zone. Scale bars: 100 mum in (A, G), which applies to (D-G); 50 mum in (D'), which applies to (D', D").
###end p 19
###begin p 20
Together, these results demonstrate that Pax6 expression in the retina decreases as progenitor cells undergo the preneurogenic to neurogenic transition. Moreover, most neurogenic retinal progenitors maintain low levels of Pax6, whereas postmitotic neurons undergo cell type-specific elevation or reduction of Pax6.
###end p 20
###begin title 21
Cell cycle-dependent Pax6 protein expression among neurogenic progenitor cells
###end title 21
###begin p 22
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A,D</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B,E</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 936 940 936 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C,F</xref>
###xml 1049 1054 1049 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G,G'</xref>
###xml 1147 1152 1147 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3H,H'</xref>
###xml 1288 1290 1288 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1298 1302 1298 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 1380 1383 1380 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
To examine when Pax6 levels change to result in the distinct Pax6 levels detected among postmitotic neurons, we monitored progression of Pax6 expression among progenitors following bromodeoxyuridine (BrdU) pulse labeling. Confocal imaging analyses showed that immediately after a 20-minute BrdU incubation, BrdU-positive cells were exclusively located within the middle stratum of the E6.5 (HH stage 30) retina, representing progenitor cells in the S phase of the cell cycle (Figure 3A). Most BrdU-labeled cells co-expressed low levels of Pax6 and none were detected in the outer one-third of the retina (Figure 3A,D). Within 30 minutes after the BrdU pulse, a few BrdU-positive cells began to appear in the ventricular surface (Figure 3B,E) and showed very low or no detectable Pax6 protein (Figure 3E). By 60 minutes after BrdU labeling, increasing numbers of BrdU-positive cells had reached the outer one-third of the retina (Figure 3C,F). Co-labeling of the M phase marker phospho-histone 3 (PH3) and BrdU was not detected at 30 minutes (Figure 3G,G') but was clearly visible at the ventricular surface 60 minutes after the BrdU pulse (Figure 3H,H'). These data indicate that the G2 phase of the cell cycle was as short as 60 minutes at this developmental stage. The detection of BrdU+ and Pax6Neg cells at the ventricular surface at 30 minutes indicated that a subset of Pax6Lo progenitor cells had begun to down regulate Pax6 protein as early as the G2 phase of the cell cycle.
###end p 22
###begin p 23
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 expression during S, G2 and M phase of the cell cycle</bold>
###xml 186 194 186 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 196 202 196 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-F) </bold>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 478 493 478 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G, G', H, H') </bold>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 741 743 741 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 891 893 891 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gcl</italic>
###xml 926 928 926 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 951 953 951 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vz</italic>
Pax6 expression during S, G2 and M phase of the cell cycle. Merged confocal immunofluorescent images of E6.5 (HH stage 30) retinas after a 20-minute bromodeoxyuridine (BrdU) pulse label in vitro. (A-F) Co-staining of BrdU and Pax6 at 0 (A, D), 30 (B, E), and 60 minutes (C, F) after the pulse label. The boxed regions in (A-C) are shown in (D-F), respectively, at twofold magnification. Note the appearance of BrdU+ cells at the ventricular surface by the 30-minute chase time. (G, G', H, H') Co-staining of phospho-histone 3 (PH3) and Pax6 at 30 (G, G') or 60 minutes (H, H') after the pulse label. The boxed regions in (G, H) are shown as separate panels in (G', H'), respectively, at twofold magnification. Note the appearance of BrdU+PH3+ double-labeled cells at the ventricular surface by the 60-minute chase time. Arrows indicate BrdU and PH3 co-labeled cells. Arrowheads point to BrdU+ cells. gcl, ganglion cell layer; vs, ventricular surface; vz, ventricular zone. Scale bar: 100 mum; the scale bar in (A) applies to (A-C, G, H).
###end p 23
###begin p 24
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 503 505 503 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 637 639 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 704 706 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 828 829 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 897 899 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
To confirm the confocal imaging results, we performed flow cytometry to analyze cellular Pax6 levels during S to G2/M progression. Immediately after 20-minute BrdU pulse labeling, BrdU+ cells were clustered in S phase (with DNA content ranging between 2n and 4n) and showed fairly uniform levels of Pax6Lo expression; whereas BrdU- cells were distributed in G1/G0 phase (2n DNA content) and G2/M phase (4n DNA content) as expected (Figure 4A, 0 hour column). At 3 hours post labeling, the cohort of BrdU+ cells appeared in the 4n DNA content territory (Figure 4A, 3 hour column). By 6 hours post BrdU labeling, increasing numbers of BrdU+ cells appeared in G2/M phase; in addition, a fraction of the BrdU+ cells clearly possessed 2n DNA content, indicating that they had completed M phase and entered G1 or G0 phase (Figure 4A, 6 hour column). Between 6 and 12 hours after pulse labeling, the BrdU+ population continued to accumulate in the G1/G0 phase and decrease in the S phase, reflecting progression of the initial BrdU-labeled cohort.
###end p 24
###begin p 25
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Divergence of Pax6 protein expression in the G2/M phase of the cell cycle</bold>
###xml 75 79 75 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 242 244 242 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 264 266 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 621 625 621 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 664 666 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 682 684 682 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 913 916 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 1014 1018 1014 1018 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 1105 1107 1105 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1216 1218 1216 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1233 1235 1233 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi</sup>
###xml 1241 1243 1241 1243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo</sup>
###xml 1252 1256 1252 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 1282 1284 1282 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1382 1383 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1439 1441 1437 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1451 1453 1449 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1464 1466 1462 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Divergence of Pax6 protein expression in the G2/M phase of the cell cycle. (A) Flow cytometric analyses of BrdU, Pax6, and DNA content among E6.5 (HH stage 30) retinal cells after a 20-minute BrdU pulse labeling. Cell density profiles of BrdU+ (upper row) and BrdU- (lower row) cells at various post-chase times are shown. The 0 hour point represents the time when cells are dissociated after the pulse label and then fixed and processed for flow cytometry. Each data point represents a minimum of 30,000 cells analyzed. The x-axis represents DNA content for G0/G1 (2n), S (between 2n and 4n), and G2/M (4n) phase cells. (B) Merged flow cytometry profiles for BrdU+ (green) and BrdU- (red) cells at 0, 3, and 6 hours post-BrdU pulse labeling. The purple frames subdivide G2/M phase cells (4n) according to Pax6 levels into high (Hi), low (Lo), and negative (Neg) categories. Between 0 and 6 hours of chasing, Pax6Hi cells clearly increased, demonstrating the Pax6 level divergence when cells enter the G2/M phase. (C) Quantification of Pax6 levels at stage 30 (E6.5) and stage 33/34 (E7.5 to 8) among BrdU+ cells that had entered G2/M phase (4n) as shown in the three boxed regions in (B). The percentages of 4n BrdU+ cells with Pax6Hi, Pax6Lo, or Pax6Neg levels among total 4n BrdU+ cells at various post-chase times are shown (N = 3; mean +/- standard error). Asterisks represent P-values between 0 hours and various chase time points: *P < 0.05; **P < 0.01; ***P < 0.001.
###end p 25
###begin p 26
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 547 549 547 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 587 588 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 592 595 592 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 659 660 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 794 795 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 884 887 884 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1087 1091 1087 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
We next quantified changes of Pax6 protein levels during the transition from the S phase to G2/M phase of the cell cycle. In the E6.5 (HH stage 30) retina when RGC production peaks, following a 20-minute BrdU pulse, an average of 10.7% of the cells were labeled by BrdU (Figure 4B). After a 3 or 6 hour chasing period, BrdU+Pax6Hi cells gradually increased in the G2/M phase population (17% of total cells, with 4n DNA content) compared to the uniform Pax6Lo level of the 0 hour BrdU+ cells (Figure 4B). Quantification of Pax6 levels among 4n BrdU+ cells showed a steady increase of BrdU+Pax6Hi cells (Figure 4C). At 30 minutes after the pulse chase, the BrdU+Pax6Hi cell population already showed a statistically significant increase (Figure 4C). After 6 hours of chase, the percentage of BrdU+Pax6Hi cells had increased from 7.0% to 20.8% (Figure 4C; N = 3). Concomitantly, the Pax6Lo progenitor cells decreased from 87.6% to 72.5% during the 6 hour chase period (Figure 4C; N = 3), reflecting altered Pax6 expression as progenitors progressed through the G2/M phase. However, the Pax6Neg cell populations did not show statistically significant changes during the chase (Figure 4C).
###end p 26
###begin p 27
###xml 251 253 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 385 389 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 397 399 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 416 419 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 436 438 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 535 537 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 603 605 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 682 684 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 763 765 759 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 818 820 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1013 1017 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C&#8211;E</xref>
###xml 1147 1151 1143 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
In order to monitor changes in Pax6 protein levels among progenitors during the entire cell cycle, we excluded postmitotic G0 cells by labeling with a combination of available neuronal markers, including Brn3a, Islet1/2, AP2alpha, and Visinin (Figure 5A). As expected, most postmitotic G0 cells positively labeled for combined neuronal markers at E7 (HH stage 32) exhibited either Pax6Neg (Figure 5B, gate a) or Pax6Hi profiles (Figure 5B, gate c). To identify S phase cells, we also pulse-labeled E7 cells with BrdU. Profiling of BrdU+ cells showed that S phase cells contained low Pax6 levels (Figure 5B, gate b; and data not shown). We then defined the G1 and G2/M cells (Figure 5B, gate d) by exclusion of both neuronal marker-positive G0 phase cells and BrdU+ S phase cells from the total cell population (Figure 5B). DNA content analyses further separated G1 and G2/M cell populations and demonstrated that G1 cells and G2/M cells exhibited a broader range of Pax6 protein levels than S phase cells (Figure 5C-E). These data again demonstrate the divergence of Pax6 levels after the S to G2/M phase transition. Furthermore, an increased Pax6Neg cell population was detected in the G2/M phase, corresponding to the peak production of cone photoreceptors at E7. These results also indicate that progenitors in the G1 phase of the cell cycle show divergent Pax6 expression, which becomes more restricted upon S phase entry.
###end p 27
###begin p 28
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Correlation of Pax6 levels in progenitors in different phases of the cell cycle</bold>
###xml 195 199 195 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 509 513 509 513 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 730 732 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 801 808 801 808 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C, D) </bold>
###xml 1065 1069 1065 1069 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
Correlation of Pax6 levels in progenitors in different phases of the cell cycle. Flow cytometric analyses of Pax6 levels among postmitotic cells and cycling progenitor cells at E7 (HH stage 32). (A) Cell density profile of total retinal cells labeled with Pax6 and a combination of neuronal markers, including Brn3a, Islet1/2, AP2a, and Visinin. Neuronal marker-positive cells (above the purple line) represent G0 cells; and neuronal marker-negative cells (below the purple line) are mostly progenitor cells. (B) Cell density profile of total retinal cells labeled with a combination of neuronal markers (same as in (A)), BrdU, and Pax6. Gated areas 'a' and 'c' represent postmitotic G0 phase cells; gated area 'b' represents BrdU+ S phase cells; gated area 'd' consists of G1, G2, and M phase cells. (C, D) Cell density profiles of G1 and G2/M phase cells (C) (as gated in area 'd') and S phase cells (D) (as gated in area 'b' in (B)) according to Pax6 levels and DNA content. In (D), G1 and G2/M cells are shown in the background as a reference to S phase cells. (E) Merged flow cytometry profiles of G1 (red), G2/M (green), and S (blue) phase progenitor cells according to Pax6 levels and DNA content. Flow cytometry profiles shown in (A, B) were generated with >85,000 cells. Numbers within each panel indicate percentage of gated cells among total cells.
###end p 28
###begin title 29
Divergent Pax6 expression in G2/M and neuronal fate specification
###end title 29
###begin p 30
###xml 264 266 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 337 339 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 370 372 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 445 449 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B,C</xref>
###xml 602 604 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 701 704 700 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 764 766 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 785 787 784 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi</sup>
###xml 793 796 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 804 808 803 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 859 861 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 889 891 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
To determine if the divergence of Pax6 levels in G2/M was correlated with progenitor cell behaviors, we performed double immunocytochemistry of Pax6 and neuronal cell markers. At E6.5 (HH stage 30) double labeling of Pax6 and the M phase marker PH3 showed that PH3+ cells occupied a zone 60 mum wide from the ventricular surface (Figure 6A). Among these, a subset of PH3+ cells abutting the ventricular surface showed no Pax6 expression (Figure 6B,C). Furthermore, flow cytometric analyses showed that, at E7 (HH stage 32), only a small proportion of the G2/M phase cells (16.2% of total cells) are PH3+ cells (1.3% of total cells). Thus, most cells with 4n DNA content, including the majority of Pax6Hi cells, were G2 phase cells (14.9% of total cells). Among PH3+ M phase cells, Pax6Hi, Pax6Lo and Pax6Neg cells corresponded to 2.3%, 78.5%, and 24.5% of PH3+ cells, respectively (Figure 6D).
###end p 30
###begin p 31
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Correlation of Pax6 changes in G2/M phase with the emergence of a neuronal marker</bold>
###xml 83 89 83 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-C) </bold>
###xml 300 302 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 309 313 309 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 587 589 587 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 744 746 744 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi</sup>
###xml 752 754 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo</sup>
###xml 764 768 764 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 820 826 820 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E-H) </bold>
###xml 1016 1022 1016 1022 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I-L) </bold>
###xml 1116 1122 1116 1122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(M-P) </bold>
###xml 1348 1349 1348 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1353 1357 1353 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg </sup>
###xml 1565 1567 1565 1567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1574 1576 1574 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
Correlation of Pax6 changes in G2/M phase with the emergence of a neuronal marker. (A-C) Confocal images of Pax6 and PH3 co-labeling at E6.5 (HH stage 30). Boxed region in (A) is shown as Pax6 and PH3 merge (B) or Pax6 alone (C) at twofold magnification, where dotted outlines in (C) encircle all PH3+ cells. (D) Flow cytometry profiles of Pax6, PH3, and DNA content at E7 (HH stage 32). For both panels the y-axes represent Pax6 levels, while the x-axes indicate the DNA content. The left panel shows merged distribution profiles of Pax6 (red) and PH3 (green), and the percentage of PH3+ cells among total cells is indicated below. The right panel shows cell density distribution with regard to Pax6 and the cell cycle. The percentages of Pax6Hi, Pax6Lo, and Pax6Neg cells among total cells are indicated at the right. (E-H) Confocal images of Visinin, PH3, and DAPI co-staining at E6.5 (HH stage 30). The boxed region in (E) is shown as Visinin- (F), PH3- (G), or DAPI staining (H) alone at twofold magnification. (I-L) Co-labeling for Visinin (J), PH3 (K), DAPI (L), and merge (I) in dissociated E6 retina cells. (M-P) Confocal images of Visinin, Pax6, and DAPI co-staining at E6.5 (HH stage 30). The boxed region in (M) is shown as Visinin (N), Pax6 (O), or DAPI staining (P) alone at twofold magnification. Yellow dotted lines encircle Visinin+Pax6Neg cells, whereas white dotted lines in (N-P) encircle a pair of cells at the end of the M-phase with weak Pax6 and Visinin signals. Arrows indicate co-labeled cells. Arrowheads point to marker-positive but Pax6- cells. vs, ventricular surface. Scale bars: 100 mum.
###end p 31
###begin p 32
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E&#8211;H</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6I&#8211;L</xref>
###xml 557 559 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6M&#8211;P</xref>
We then examined whether G2/M progenitors with no Pax6 corresponded to committed cone photoreceptors, which at maturity contain no Pax6. Confocal imaging revealed that the early cone cell marker Visinin could be detected in PH3+ cells (Figure 6E-H), suggesting that the onset of Visinin expression begins during the M phase. This was further confirmed in dissociated retinal cell cultures, where we detected co-labeling of PH3 with weak Visinin signals in anaphase progenitors (Figure 6I-L). Furthermore, confocal imaging demonstrated that intensely Visinin+ cone photoreceptor precursors expressed no Pax6, whereas cells emerging from the telophase expressed both low levels of Pax6 and Visinin (Figure 6M-P). These data suggested that the emergence of the cone marker Visinin correlated with the down-regulation of Pax6 in a subset of M phase cells. Therefore, the divergence of Pax6 expression among a subset of progenitors in G2/M phase of the cell cycle may reflect neuronal fate specification.
###end p 32
###begin title 33
Effects of altering Pax6 levels on proliferation, neuronal fate specification, and cell death
###end title 33
###begin p 34
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5a</italic>
###xml 399 404 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i</italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 867 872 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i</italic>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 1030 1035 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1038 1042 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 1043 1045 1043 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5a</italic>
###xml 1149 1151 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
In order to determine whether Pax6 expression levels are critical in the neurogenic progenitor cells, we perturbed Pax6 expression using small hairpin RNA (shRNA) knockdown and overexpression in the E4 to E4.5 (HH stages 22 to 24) central retina. A conserved 21-nucleotide region in the paired domain shared between Pax6 and Pax6(5a) was selected and cloned downstream of the mouse U6 promoter as a Pax6 shRNA cassette (Figure 7A). In transient transfection assays in 293T cells, the shRNA targeting Pax6 (Pax6i) showed more than 90% efficiency in knocking down co-expressed Pax6 protein, but did not affect expression of the control red fluorescent protein (RFP; Figure 7B). Similarly, E4 (HH stages 23 to 24) primary retinal cells transfected with Pax6i showed reduced expression of endogenous Pax6 protein (Figure 7C). This was confirmed by quantification, as the Pax6i-transfected population displayed a shift from higher to lower Pax6 levels (Figure 7D). In addition, in retinal cells transfected with vectors overexpressing Pax6 or Pax6(5a) cDNA, significantly higher levels of Pax6 protein compared to endogenous levels were detected (Figure 7E).
###end p 34
###begin p 35
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effectiveness of Pax6 knockdown and overexpression</bold>
###xml 52 56 52 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 188 192 188 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Redi1 </italic>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Redi2</italic>
###xml 520 524 520 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 629 638 629 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 645 651 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 746 750 746 750 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 900 901 900 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 937 943 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 953 955 953 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 998 1002 994 998 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 1103 1108 1099 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1111 1115 1107 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 1116 1118 1112 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5a</italic>
###xml 1166 1171 1162 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1175 1179 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 1180 1182 1176 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5a</italic>
Effectiveness of Pax6 knockdown and overexpression. (A) Schematics show small hairpin RNA (shRNA) target location in Pax6 and Pax6 5a and the structure of the U6 shRNA construct (bottom). (B) Western blots show Pax6 shRNA knockdown in transfected 293T cells. DNAs used are listed on the top and antibodies used are on the left of the blots. U6, control vector used to express shRNA; Pax6i, U6 vector expressing shRNA targeting Pax6; Redi1 and Redi2, U6 vectors expressing shRNAs targeting red fluorescent protein (RFP). (C) Immunolabeling shows Pax6 protein knockdown in transfected E4.5 (HH stage 24) retinal cells after 2 days in vitro (DIV). Pax6i transfected samples showed fewer cells co-expressing green fluorescent protein (GFP) and Pax6. (D) Quantification of Pax6 protein signal intensities among U6 vector and U6-Pax6i vector transfected E4.5 retinal cells after 2 DIV. Asterisks represent P-values between the control and the Pax6i samples: *P < 0.05 (N >/= 4, mean +/- standard error). (E) Immunofluorescent staining of E5 (HH stage 27) retinal cells transfected with CAG control vector and Pax6 or Pax6(5a) overexpression vectors after 2 DIV. Note both Pax6 and Pax6(5a) expression vector-transfected cells show higher Pax6 expression levels than endogenous Pax6 levels observed in retinal cells.
###end p 35
###begin p 36
###xml 192 198 192 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 328 330 328 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A,G</xref>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 60 67 <span type="species:ncbi:9031">chicken</span>
We next examined the effects of altering Pax6 levels during chicken retinogenesis using explant cultures. Quantification of proliferating cell marker PCNA showed that retinas transfected with Pax6i at E4.5 (HH stage 24) reduced cycling cells from 66.7% to 49.5%, whereas overexpressing Pax6 did not affect the proportion of PCNA+ cells (Figure 8A,G). In comparison, both Pax6 shRNA knockdown and Pax6 overexpression caused significant decreases in overall BrdU incorporation (Figure 8B), suggesting that Pax6 levels affected the proportion of cells undergoing DNA synthesis.
###end p 36
###begin p 37
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of altering Pax6 expression on cell proliferation and fate specification</bold>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 252 260 252 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 363 369 361 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-E) </bold>
###xml 487 489 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 508 512 506 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) </bold>
###xml 570 572 568 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 675 679 673 677 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 791 796 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 809 814 803 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 82 89 <span type="species:ncbi:9031">Chicken</span>
Effects of altering Pax6 expression on cell proliferation and fate specification. Chicken retinal explants were transfected with Pax6 shRNA expression or Pax6 overexpression vectors at E4.5 (HH stage 24). Cell marker assays were performed after 3 days in vitro. Statistically significant sample pairs are indicated with asterisks and specific P-values (N >/= 4). (A-E) Bar graphs showing percentages of cell marker and green fluorescent protein (GFP) double positive cells over total GFP+ transfected cells. (F) Compilation of cell type markers among all transfected GFP+ cells under control and Pax6 perturbation conditions. The mean values were used to generate the graph. (G) Summary of the percentages of cell markers and deviations (N >/= 4, mean +/- standard error) under controls and Pax6 knockdown or Pax6 overexpression conditions. BrdU, bromodeoxyuridine; PCNA, proliferating cell nuclear antigen.
###end p 37
###begin p 38
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C,G</xref>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E,G</xref>
###xml 519 521 519 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 586 588 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 691 693 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 958 962 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F,G</xref>
We also examined the influence of Pax6 levels on three major neuronal cell types generated between HH stage 24 and stage 32. Reducing Pax6 by shRNA resulted in a decrease of Brn3a+ retinal ganglion cells from 4.3% to 1.2% (Figure 8C,G). However, Pax6 overexpression did not elevate the production of Brn3a+ RGCs (Figure 8C). Quantification using Visinin showed that reducing Pax6 using shRNA dramatically enhanced cone precursors from 24.6% to 40.5% (Figure 8E,G). Conversely, overexpressing Pax6 caused reduced Visinin+ cone precursor production (Figure 8E). The production of AP2alpha+ amacrine cells was enhanced when Pax6 was down-regulated and suppressed when Pax6 was elevated (Figure 8D), suggesting that amacrine interneuron specification was also sensitive to Pax6 levels. Together, these results demonstrate that Pax6 expression levels among neurogenic progenitor cells critically affect both cell proliferation and neuronal fate decisions (Figure 8F,G).
###end p 38
###begin p 39
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A,B</xref>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 541 543 541 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C,D</xref>
###xml 724 730 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 759 761 759 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9E</xref>
###xml 869 871 869 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9F</xref>
Since the small eye phenotype associated with Pax6 mutations may potentially be caused by increased cell death in the retina, we also examined the effects of altering Pax6 expression levels on cell death. In control retinal explants, activated caspase 3 signals were detected; however, they were not often associated with green fluorescent protein (GFP)-positive transfected cells (Figure 9A,B). In contrast, in retinal explants transfected with the Pax6i plasmid, increased caspase 3 signals were detected and they often corresponded to GFP+ transfectants (Figure 9C,D). The effects of altering Pax6 expression levels on cell death were further assessed in monolayer retinal cultures. Compared to mock transfected samples, Pax6i knockdown increased caspase 3+ cells from 6.8% to 9.1% (Figure 9E). Overexpression of Pax6(5a) but not Pax6 resulted in increased caspase 3+ cells compared to controls (Figure 9F). Therefore, decreasing Pax6 and/or Pax6(5a) or increasing Pax6(5a) resulted in more cell death.
###end p 39
###begin p 40
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of altering Pax6 expression on cell death</bold>
###xml 51 57 51 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-D) </bold>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i </italic>
###xml 200 208 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 344 346 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 373 375 373 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6i</italic>
###xml 532 539 532 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E, F) </bold>
###xml 562 564 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 666 674 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 838 841 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gcl</italic>
###xml 864 866 862 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
Effects of altering Pax6 expression on cell death. (A-D) Immunofluorescent images of retinal explants transfected at E4.5 (HH stage 24) with U6 control (A, B) and U6-Pax6i (C, D) vectors after 2 days in vitro. (A, C) Merged images for green fluorescent protein (GFP), activated caspase 3 (Casp3, red), and DAPI. (B, D) Merged images showing GFP+ transfected cells and Casp3+ signals. Note that Pax6i-transfected retinas show higher levels of apoptosis than the U6 control. Arrows in (D) indicate cells co-labeled for GFP and Casp3. (E, F) Quantification of Casp3+ cells among GFP+-transfected cells in dissociated E5 (HH stage 27) retinal cell cultures after 2 days in vitro. Statistically significant data points between the controls and given samples are indicated with asterisks and specific P-values (N = 3, mean +/- standard error). gcl, ganglion cell layer; vs, ventricular surface.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 127 134 <span type="species:ncbi:9031">chicken</span>
In this study, we have analyzed Pax6 protein expression during the preneurogenic to neurogenic transition and among neurogenic chicken retinal progenitor cells. We provide evidence that Pax6 protein levels are highly dynamic in proliferating progenitors and are coupled with cell cycle progression. We also demonstrate that Pax6 levels critically influence cell proliferation and cell fate specification of neurogenic progenitors.
###end p 42
###begin p 43
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1059 1062 1059 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo </sup>
###xml 1081 1084 1081 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi </sup>
###xml 1150 1155 1150 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 1338 1340 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1341 1343 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1424 1428 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crx </italic>
###xml 1434 1436 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1656 1661 1652 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ath5 </italic>
###xml 1665 1669 1661 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ngn2</italic>
Pax6 is expressed by retinal progenitors throughout development. However, our results show that Pax6 protein levels are significantly down-regulated as retinal progenitors undergo the preneurogenic to neurogenic transition and initiate production of postmitotic neurons. During the remainder of retinogenesis, the peripheral margin progenitor cells retain a higher level of Pax6 compared to the central progenitor cells. How the down-regulation of Pax6 expression is achieved during the preneurogenic to neurogenic transition remains unknown, but it may involve signals that promote cell-intrinsic changes necessary to enable cell cycle exit and neuronal fate specification. The differing levels of Pax6 in the peripheral versus central retina are achieved, in part, at the transcriptional level through the complex arrays of Pax6 enhancers [17,19]. Our data suggest that translational and/or post-translational regulation may also contribute to the rapid change of Pax6 protein levels during the cell cycle. The cellular distinctions between the central Pax6Lo and peripheral Pax6Hi progenitors are not well understood. Conditional ablations of the Pax6 gene in the peripheral retina by Pax6 alpha-cre and in the central retina by the Chx10-cre both block expression of proneural genes and limit the pluripotency of retinal progenitors [40,41]. However, the peripherally expressed Pax6 also plays a role in suppressing the Crx gene [41], suggesting either a context-dependent or dosage-dependent mechanism. The Pax6 perturbation carried out in our study focused on the central neurogenic retina, where the expression of several proneural genes, including Ath5 and Ngn2, has begun and postmitotic neurons have accumulated. Thus, our experiments address the importance of Pax6 regulation among neurogenic progenitors.
###end p 43
###begin p 44
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 912 914 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1120 1122 1120 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
We have established by quantitative flow cytometry analysis that the cycling neurogenic progenitor population expresses a relatively low level of Pax6, which when perturbed interferes with BrdU incorporation. Interestingly, overexpression of Pax6 resulted in a decreased number of cells undergoing DNA synthesis, but did not significantly impact the proportion of PCNA+ cells remaining in the cell cycle. Since PCNA labels proliferating cells in all phases of the cell cycle, this result suggests that high Pax6 levels potentially alter cell cycle distribution and/or lead to cell cycle arrest. Consistent with our observations, studies in the developing cortex have shown that reducing Pax6 perturbs cell cycle length and affects the preneurogenic to neurogenic transition [30,31]. In addition, activation of Pax6 or Pax6(5a) above endogenous levels in the cortical progenitors disrupts cell cycle progression [28]. Live imaging of a tagged Pax6 isoform has revealed that Pax6p46 is associated with the pericentromeric area of the chromosomes during M phase, and overexpression of this isoform causes abnormal mitosis [44]. Our study shows that low levels of Pax6 are expressed by the majority of neurogenic progenitors, but progenitor cells residing within the S phase appear to maintain a more uniformly low level of Pax6 compared to G1 and G2/M phase cells. This raises the possibility that the G1 to S phase transition of neurogenic progenitors may require a narrow range of Pax6 protein. Further analyses are necessary to determine the precise cell cycle defects of retinal progenitors with aberrant levels of Pax6 expression.
###end p 44
###begin p 45
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Math5 </italic>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 177 192 <span type="species:ncbi:10090">transgenic mice</span>
Previous findings show that heterozygous Pax6 loss of function mutations lead to microphthalmia in mice [8-12], which is primarily due to defects in early eye morphogenesis. In transgenic mice carrying multiple copies of Pax6, the eye morphology and retinogenesis are initially normal, but RGC axons show dose-dependent projection defects accompanied by postnatal cell loss [12,13]. This suggests that Pax6 levels affect RGC differentiation and survival. Since Pax6 positively regulates transcription of the proneural gene Math5 required for RGC development [45], high levels of Pax6 may cause inappropriate Math5 expression, leading to RGC death. Consistent with the finding that aberrant Pax6 levels cause increased apoptosis during cortical development [28], we have detected increased cell death due to reduced Pax6 or increased Pax6(5a) levels in the neurogenic retina. These findings indicate that stringent regulation of Pax6 levels is critical for cell survival at different stages of eye/retinal development.
###end p 45
###begin p 46
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1500 1502 1500 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 353 360 <span type="species:ncbi:9031">chicken</span>
###xml 783 790 <span type="species:ncbi:9031">chicken</span>
###xml 1145 1152 <span type="species:ncbi:9031">chicken</span>
###xml 1595 1602 <span type="species:ncbi:9031">chicken</span>
We have demonstrated that various postmitotic retinal neurons exhibit distinct Pax6 levels, suggesting that Pax6 expression is readjusted when neurogenic progenitors become postmitotic, and that Pax6 may, therefore, function in cell fate determination of progenitors and/or subsequent neuronal differentiation. Our data show that perturbing Pax6 during chicken retinogenesis impacts cell fate specification. In close correlation with the contrasting levels of Pax6 in mature RGCs and cone photoreceptors, decreasing Pax6 led to reduced RGC and enhanced photoreceptor genesis. Conversely, forced expression of Pax6 suppressed photoreceptor production. However, we did not detect increased RGC production due to forced Pax6 expression as previously observed in a low density monolayer chicken retinal culture [46]. This might be due to the progenitors in our retinal explants already expressing sufficient amounts of Pax6 to facilitate RGC fate specification. Alternatively, Pax6 overexpression enhances early neuronal markers but not the more mature RGC marker Brn3a. The majority of postmitotic amacrine cells express high levels of Pax6 in the chicken retina. Our results show that both reducing and elevating Pax6 altered amacrine production, supporting a requirement for Pax6 in either specification or differentiation of amacrine interneurons. This result is consistent with phenotypes of Pax6 conditional knockout in the more centrally localized progenitors, which also lose their pluripotency [41]. The fact that both gain and loss of Pax6 function impede amacrine cell development in the chicken retina suggests that Pax6 is likely required for amacrine cell fate specification rather than differentiation, but direct perturbation of Pax6 in postmitotic amacrine cells is necessary to distinguish these possibilities.
###end p 46
###begin p 47
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
In this study, we present the first analysis of Pax6 protein dynamics with regard to the neurogenic cell cycle. We provide evidence that a subset of neurogenic progenitor cells begins to display divergent Pax6 protein levels upon entering into the G2 phase of the cell cycle. This cell cycle-correlated Pax6 protein level change is more readily detectable in the later neurogenic retina (Figures 4, 5, and 6). The dramatic changes of Pax6 levels among the subset of progenitors, coupled with the relatively short G2 phase, indicate that Pax6 protein in neurogenic progenitors may be subjected to rapid proteolytic degradation. In addition, the correlation between decreased Pax6 expression and the appearance of the neuronal marker Visinin in late M phase cells suggests that the subset of progenitor cells showing divergent Pax6 expression in G2/M are likely those that have committed to certain cell fates. Therefore, neuronal fate determination is likely to have occurred prior to the G2 phase of the neurogenic cell cycle, which produces at least one postmitotic neuron.
###end p 47
###begin p 48
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi</sup>
###xml 284 286 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo</sup>
###xml 662 664 662 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Hi</sup>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Neg</sup>
###xml 777 779 777 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lo</sup>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
Based on our results, we propose that preneurogenic retinal progenitor cells maintain a high level of Pax6 (*Pax6Hi), which by an unknown mechanism undergoes a substantial down-regulation when cells enter the neurogenic phase. Neurogenic progenitors maintain a low level of Pax6 (Pax6Lo), which is essential for sustaining cell proliferation, survival, and neuronal fate selection. Under the influence of unidentified extrinsic and/or intrinsic cues, a subset of progenitors alters their Pax6 levels upon entry into the G2/M phase in preparation for cell cycle exit. Postmitotic neurons display distinct cell type-specific levels of Pax6, ranging from high (Pax6Hi) to no Pax6 (Pax6Neg), whereas G1 progenitor cells maintain or regain the characteristic low level of Pax6 (Pax6Lo) before the G1 to S transition (Figure 10). Results reported here reveal important functions of Pax6 during the neurogenic phase of retinal development and the dynamic nature of Pax6 protein regulation within the cell cycle. Future investigations probing mechanisms that regulate this cell cycle-dependent expression of Pax6 among progenitor cells will enhance our understanding of how progenitor proliferation and fate specification are coordinated.
###end p 48
###begin p 49
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 expression during cell cycle progression and a model of cell cycle-dependent Pax6 regulation</bold>
Pax6 expression during cell cycle progression and a model of cell cycle-dependent Pax6 regulation. A model of dynamic Pax6 expression during retinogenesis is depicted. Pax6 protein levels decrease in progenitor cells during the transition from the preneurogenic (indicated with an asterisk) to the neurogenic stage. Neurogenic progenitors express low levels of Pax6 protein, which is essential for maintaining the proliferative state, especially the reentry of S phase. The cohort of S phase cells contains a relatively uniform level of low Pax6. Upon entering into the G2/M phase, the neurogenic progenitor population displays more divergent Pax6 levels, with a subset of progenitor cells showing increased or decreased Pax6 protein expression depending on the developmental stage. Because postmitotic neurons contain distinct levels of Pax6 protein, the divergence of Pax6 expression during the G2/M phase may forecast cell fate specification at or prior to the G2 phase of the cell cycle. Postmitotic neurons achieve and maintain specific and distinct levels of Pax6 during differentiation. RGC, retinal ganglion cell.
###end p 49
###begin title 50
Conclusion
###end title 50
###begin p 51
During the preneurogenic to neurogenic transition, retinal progenitor cells undergo dramatic down-regulation of Pax6 protein. A low level of Pax6 protein is essential for S phase entry and normal proliferation of neurogenic progenitors. A subset of neurogenic progenitors rapidly increase or decrease Pax6 levels in the G2/M phase of the cell cycle, forecasting cell fate selections prior to G2. The dynamic regulation of Pax6 protein within the cell cycle is critical for the expansion and fate specification of neurogenic progenitors.
###end p 51
###begin title 52
Materials and methods
###end title 52
###begin title 53
###xml 0 7 <span type="species:ncbi:9031">Chicken</span>
Chicken embryos
###end title 53
###begin p 54
###xml 231 233 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 25 32 <span type="species:ncbi:9031">chicken</span>
Fertilized White Leghorn chicken eggs were purchased from Charles River (Wilmington, MA, USA) and were incubated at 38degreesC in a rotating humidified incubator. Embryos were staged (HH stage) according to Hamburger and Hamilton [47].
###end p 54
###begin title 55
DNA constructs
###end title 55
###begin p 56
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 76 78 76 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5a</italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 940 946 940 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Redi1 </italic>
###xml 950 956 950 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Redi2 </italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 104 111 <span type="species:ncbi:9031">chicken</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:10090">mouse</span>
Overexpression constructs were generated by cloning the human Pax6 and Pax6(5a) cDNAs downstream of the chicken beta actin enhanced cytomegalovirus promoter (CAG)[48] followed by an internal ribosomal entry site upstream of the human placental alkaline phosphatase. For shRNA-mediated knockdown, hairpin sequences specifically targeting Pax6 or the control RFP message (HcRed N1; Clonetech, Mountain View, CA, USA) were cloned downstream of the mouse U6 promoter in the vector pBS/U6 (U6) [49]. In addition, a cassette containing the CAG promoter and a nuclear GFP was cloned downstream of the of U6 shRNA cassette in the same orientation. The set of specific primers used to generate the shRNAs targeting Pax6 were: XJY276 (5'GGTCTGTACCAACGATAACAA); XJY277 (5'AGCTTTGTTATCGTTGGTACAGACC); XJY278 (5'AGCTTTGTTATCGTTGGTACAGACCCTTTTTG); XJY279 (5'AATTCAAAAAGGGTCTGTACCAACGATAACAA). The two sets of specific primers used to generate the shRNAs Redi1 and Redi2 targeting HcRed N1 (Clonetech) were:
###end p 56
###begin p 57
Redi1, XJY694 (5'GGCACCGTGAACGGCCACTACTTA), XJY695 (5'AGCTTAAGTAGTGGCCGTTCACGGTGCC), XJY696 (5'AGCTTAAGTAGTGGCCGTTCACGGTGCCCTTTTTG), XJY697 (5'AATTCAAAAAGGGCACCGTGAACGGCCACTACTTA); Redi2, XJY698 (5'GGAGAGAACCACCACCTACGAA), XJY699 (5'AGCTTTCGTAGGTGGTGGTTCTCTCC), XJY700 (5'AGCTTTCGTAGGTGGTGGTTCTCTCCCTTTTTG), XJY701 (5'AATTCAAAAAGGGAGAGAACCACCACCTACGAA).
###end p 57
###begin title 58
Retinal cultures and transfection assays
###end title 58
###begin p 59
###xml 182 183 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1100 1102 1093 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1005 1009 <span type="species:ncbi:9913">calf</span>
###xml 1022 1029 <span type="species:ncbi:9031">chicken</span>
For transfection of monolayer cells, dissociated HH stage 27 retinal cells were plated on poly-D-lysine coated 8-well LabTek (Nalge Nunc, Rochester NY, USA) slides at 20,000 cells/mm2, 3 hours prior to Lipofectamine PLUS (Invitrogen, Carlsbad, CA, USA) transfection using Pax6 shRNA knockdown vectors or Pax6 overexpression vectors with a CAG-nGFP plasmid at 2:1 ratio [50]. For transfection of retinal tissues, DNA at 2 mug/ml in phosphate-buffered saline (PBS) was injected into the subretinal space of the eye at HH stage 24/25. The injected eyes were placed between paddle electrodes and subjected to five pulses at 10 V/mm for 25 ms with 975-ms intervals using ECM 830 Square Wave Electroporation System (BTX, Holliston, MA, USA). Central retinas (posterior halves) were dissected from electroporated eyes and cultured on Nucleopore membrane discs (Millipore, Billerica, MA, USA) floating on a retinal culture medium containing an equal ratio of F12:DMEM (JRH Biosciences, Lenexa, KS, USA), 2% fetal calf serum, 0.2% chicken serum, 10 mM HEPES, and penicillin/streptomycin at 37degreesC in 5% CO2 for 72 hours.
###end p 59
###begin p 60
###xml 181 184 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 714 725 <span type="species:ncbi:3704">horseradish</span>
Transfection of 293T cells was carried out using Lipofectamine PLUS (Invitrogen) and 0.65 mug of U6-Pax6i, U6-Redi1, U6-Redi2, or U6-GFP with 0.5 mug of either RCAS(B)-hPax6 DNA or CMV-HcRedN1 (RFP) as well as 0.35 mug of CAG-nGFP as transfection control. At 48 hours post-transfection, cells were lysed in RIPA buffer without deoxycholate, protein extracts were resolved on a 10% BisTris SDS-PAGE gel using MOPS buffer (Invitrogen), and transferred onto nitrocellulose membrane. Blots were probed with antibodies against GFP (1:500; Invitrogen), HcRedN1 (1:500; Becton Dickenson, Laguna Hills, CA, USA), Pax6 (1:1,000; Chemicon/Millipore, Billerica, MA, USA), and followed by secondary antibodies conjugated with horseradish peroxidase and detected by enhanced chemiluminescence (ECL plus; Amersham, Piscataway, NJ, USA).
###end p 60
###begin title 61
Immunohistochemistry and imaging
###end title 61
###begin p 62
###xml 9 16 <span type="species:ncbi:9031">chicken</span>
Heads of chicken embryos or retinal explants were fixed in 4% paraformaldehyde in PBS overnight at 4degreesC, followed by cryoprotection with 30% sucrose in PBS and embedding in OCT. Coronal sections 20 mum thick were collected and used for immunolabeling. For BrdU pulse labeling, the posterior half of HH stage 30 or stage 33 to 34 retinas were dissected and incubated in the retinal culture medium supplemented with 20 mum BrdU for 20 minutes, followed by extensive washes in fresh culture medium without BrdU, and then further cultured as free floating explants for designated time periods. Retinal cryosections labeled with BrdU were treated with 95% formamide in 1x standard sodium citrate (SSC) pH7.4 for 10 minutes at 70degreesC prior to antibody incubation.
###end p 62
###begin p 63
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
###xml 238 244 <span type="species:ncbi:9986">rabbit</span>
###xml 290 296 <span type="species:ncbi:9986">rabbit</span>
###xml 343 346 <span type="species:ncbi:10116">rat</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 456 462 <span type="species:ncbi:9986">rabbit</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
###xml 549 554 <span type="species:ncbi:10090">mouse</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 614 619 <span type="species:ncbi:10090">mouse</span>
###xml 656 661 <span type="species:ncbi:10090">mouse</span>
###xml 697 703 <span type="species:ncbi:9986">rabbit</span>
###xml 738 743 <span type="species:ncbi:10090">mouse</span>
###xml 770 775 <span type="species:ncbi:10090">mouse</span>
###xml 791 797 <span type="species:ncbi:9986">rabbit</span>
###xml 910 921 <span type="species:ncbi:3704">horseradish</span>
Immunohistochemistry was performed as previously described [51]. Cryosections or monolayer cells were incubated with the following primary antibodies: Neurofilament 68 (mouse, 1:200; Sigma Aldrich, St. Louis, MO, USA), Neurofilament 145 (rabbit, 1:500; Chemicon), Phospho-histone H3 ser28 (rabbit, 1:500; Millipore), Phospho-histone H3 ser10 (rat monoclonal, 1:250; Sigma), Pax6 (mouse, 1:10; Developmental Study Hybridoma Bank, Iowa City, IA, USA), Pax6 (rabbit, 1:500; Chemicon and Covance, Princeton, NJ, USA), PCNA (mouse, 1:200; Sigma), Brn3a (mouse, 1:200; Chemicon), AP2alpha (mouse, 1:5; DSHB), Islet 1/2 (mouse clone 39.4D5, 1:10; DSHB), Visinin (mouse, 1:50; DSHB), activated caspase 3 (rabbit, 1:250; Upstate/Millipore), BrdU (mouse, 1:5; Amersham), and GFP (mouse monoclonal and rabbit polyclonal; Invitrogen). Sections were then incubated with either biotinylated secondary antibodies followed by horseradish peroxidase detection (Vector Laboratories, Burlingame, CA, USA) using 3,3'-diaminobenzidine (Sigma), or appropriate secondary antibodies conjugated to Alexa 488, 568, 594, or 647 (Invitrogen). For nuclear staining, 1 mg/ml of 4',6-diamidino-2-phenylindole (DAPI; Roche, Palo Alto, CA, USA) was used. Epifluorescent and DIC images were captured using a Nikon E800 microscope equipped with a SPOTII digital camera. Confocal optic sections 1 mum thick were obtained using a Zeiss LSM 410 confocal laser-scanning system with a Zeiss Axiovert 135M microscope, or a Leica TCS SP MP confocal microscope.
###end p 63
###begin title 64
Flow cytometry
###end title 64
###begin p 65
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 182 184 182 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 190 192 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 628 629 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 664 666 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 282 289 <span type="species:ncbi:3847">Soybean</span>
###xml 357 364 <span type="species:ncbi:9031">chicken</span>
The anterior (st25 analysis) and posterior halves of retinas were dissected and collected in Hank's buffer saline solution (HBSS+; Invitrogen). Retinas were washed in HBSS without Mg+ and Ca+ (HBSS-; Invitrogen) and incubated with 0.1% trypsin (Sigma) at 37degreesC for 10 minutes. Soybean trypsin inhibitor (Sigma) at a final concentration of 0.1 mg/ml or chicken serum (Sigma) to 10% of total volume was added to stop trypsin, followed by addition of DNaseI (Sigma) to 50 mg/ml and trituration to obtain single cell suspensions. Single cell suspensions were fixed in 2% paraformaldehyde in PBS for 30 minutes, washed with HBSS+, followed by 0.1% Triton-X in HBSS+ incubation prior to staining with primary and secondary antibodies as described above with washes in between. Anti-PCNA and anti-BrdU antibody labeled cells were also treated with 2 N and 1 N HCl, respectively, prior to antibody labeling. Cells were filtered and collected using a tube with a 35 mm nylon mesh cap (BD Biosciences/Falcon, San Jose, CA, USA) before flow cytometry analyses using an LSR flow cytometer (BD Biosciences).
###end p 65
###begin title 66
Quantification of cell markers and statistical analysis
###end title 66
###begin p 67
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 613 615 613 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Quantification of various cell markers for dissociated retinal cells was performed by counting non-overlapping fields through the microscope directly or by analyzing acquired digital images using ImagePro PLUS software (Media Cybernetics, Bethesda, MD, USA). For each sample, a minimum of 200 marker-positive cells or the entire 7-mm diameter well was counted. Quantification of dissociated retinal cells by FACS was performed using FlowJo v5.7.2 according to the manufacturer's guidelines (Ashland, OR, USA). For each sample, a minimum of 30,000 cells was analyzed. Student t-test was applied to data sets where P < 0.05 is considered statistically significant. Data were presented as mean +/- SEM.
###end p 67
###begin title 68
Abbreviations
###end title 68
###begin p 69
###xml 25 28 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
BrdU: bromodeoxyuridine; CMV: cytomegalovirus; E: embryonic day; GFP: green fluorescent protein; HH: Hamburger and Hamilton; PBS: phosphate-buffered saline; PCNA: proliferating cell nuclear antigen; PH3: phospho-histone 3; RFP: red fluorescent protein; RGC: retinal ganglion cell; shRNA: small hairpin RNA.
###end p 69
###begin title 70
Competing interests
###end title 70
###begin p 71
The authors declare that they have no competing interests.
###end p 71
###begin title 72
Authors' contributions
###end title 72
###begin p 73
YWH participated in the design of the study, carried out the experiments, and helped to draft the manuscript. X-JY participated in the design of the study and wrote the manuscript. Both authors read and approved the final manuscript.
###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
Additional file 1
###end title 75
###begin p 76
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 levels among cells in different phases of the cell cycle</bold>
Pax6 levels among cells in different phases of the cell cycle. Pax6 levels among cells in different phases of the cell cycle.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Acknowledgements
###end title 78
###begin p 79
We thank Dr Joseph Horwitz for advice and support, and Drs Mathew Schibler and Ingrid Schmidt for assistance on confocal imaging and flow cytometry, respectively. This work was supported in part by NEI T32 training grant to Y-WH, and grants from the Research to Prevent Blindness Foundation, the Karl Kirchgessner Foundation, the Foundation Fighting Blindness and the National Eye Institute to X-JY.
###end p 79
###begin article-title 80
###xml 75 80 <span type="species:ncbi:9606">human</span>
Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene
###end article-title 80
###begin article-title 81
###xml 72 82 72 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila
###end article-title 81
###begin article-title 82
New perspectives on eye development and the evolution of eyes and photoreceptors
###end article-title 82
###begin article-title 83
Pax6 lights-up the way for eye development
###end article-title 83
###begin article-title 84
###xml 32 43 32 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 89 95 <span type="species:ncbi:9606">humans</span>
Homology of the eyeless gene of Drosophila to the Small eye gene in mice and Aniridia in humans
###end article-title 84
###begin article-title 85
The master control gene for morphogenesis and evolution of the eye
###end article-title 85
###begin article-title 86
Pax6 induces ectopic eyes in a vertebrate
###end article-title 86
###begin article-title 87
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse small eye results from mutations in a paired-like homeobox-containing gene
###end article-title 87
###begin article-title 88
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Disruption of PAX6 function in mice homozygous for the Pax6Sey-1Neu mutation produces abnormalities in the early development and regionalization of the diencephalon
###end article-title 88
###begin article-title 89
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
Small eyes (Sey): a homozygous lethal mutation on chromosome 2 which affects the differentiation of both lens and nasal placodes in the mouse
###end article-title 89
###begin article-title 90
PAX-6 in development and evolution
###end article-title 90
###begin article-title 91
Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities
###end article-title 91
###begin article-title 92
Overexpression of Pax6 results in microphthalmia, retinal dysplasia and defective retinal ganglion cell axon guidance
###end article-title 92
###begin article-title 93
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Small eye (Sey): a mouse model for the genetic analysis of craniofacial abnormalities
###end article-title 93
###begin article-title 94
PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects
###end article-title 94
###begin article-title 95
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus
###end article-title 95
###begin article-title 96
Pax6 is required for establishing naso-temporal and dorsal characteristics of the optic vesicle
###end article-title 96
###begin article-title 97
Spatial specification of mammalian eye territories by reciprocal transcriptional repression of Pax2 and Pax6
###end article-title 97
###begin article-title 98
Distinct cis-essential modules direct the time-space pattern of the Pax6 gene activity
###end article-title 98
###begin article-title 99
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Regulation of Pax6 expression is conserved between mice and flies
###end article-title 99
###begin article-title 100
Mechanisms controlling Pax6 isoform expression in the retina have been conserved between teleosts and mammals
###end article-title 100
###begin article-title 101
###xml 32 38 <span type="species:ncbi:9913">bovine</span>
Alternative splicing of Pax6 in bovine eye and evolutionary conservation of intron sequences
###end article-title 101
###begin article-title 102
Nuclear localization signals, DNA binding, and transactivation properties of quail Pax-6 (Pax-QNR) isoforms
###end article-title 102
###begin article-title 103
Analysis of Pax6 expression using a BAC transgene reveals the presence of a paired-less isoform of Pax6 in the eye and olfactory bulb
###end article-title 103
###begin article-title 104
###xml 61 66 <span type="species:ncbi:9606">human</span>
Quantitation of PAX6 and PAX6(5a) transcript levels in adult human lens, cornea, and monkey retina
###end article-title 104
###begin article-title 105
###xml 91 114 91 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 91 114 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Growth and specification of the eye are controlled independently by Eyegone and Eyeless in Drosophila melanogaster
###end article-title 105
###begin article-title 106
Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development
###end article-title 106
###begin article-title 107
###xml 59 74 <span type="species:ncbi:10090">transgenic mice</span>
Conditional activation of Pax6 in the developing cortex of transgenic mice causes progenitor apoptosis
###end article-title 107
###begin article-title 108
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Iris hypoplasia in mice that lack the alternatively spliced Pax6(5a) isoform
###end article-title 108
###begin article-title 109
Pax6 is required to regulate the cell cycle and the rate of progression from symmetrical to asymmetrical division in mammalian cortical progenitors
###end article-title 109
###begin article-title 110
Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies cortical cell identity by a cell autonomous mechanism
###end article-title 110
###begin article-title 111
The on/off of Pax6 controls the tempo of neuronal differentiation in the developing spinal cord
###end article-title 111
###begin article-title 112
Multipotent precursors can give rise to all major cell types of the frog retina
###end article-title 112
###begin article-title 113
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 30 37 <span type="species:ncbi:8355">Xenopus</span>
Cellular determination in the Xenopus retina is independent of lineage and birth date
###end article-title 113
###begin article-title 114
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Lineage-independent determination of cell type in the embryonic mouse retina
###end article-title 114
###begin article-title 115
###xml 53 56 <span type="species:ncbi:10116">rat</span>
A common progenitor for neurons and glia persists in rat retina late in development
###end article-title 115
###begin article-title 116
Cell fate determination in the vertebrate retina
###end article-title 116
###begin article-title 117
Vertebrate neural cell-fate determination: lessons from the retina
###end article-title 117
###begin article-title 118
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 73 80 <span type="species:ncbi:8355">Xenopus</span>
The genetic sequence of retinal development in the ciliary margin of the Xenopus eye
###end article-title 118
###begin article-title 119
Pax6 is required for the multipotent state of retinal progenitor cells
###end article-title 119
###begin article-title 120
Dual requirement for Pax6 in retinal progenitor cells
###end article-title 120
###begin article-title 121
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
In situ hybridization
###end article-title 121
###begin article-title 122
Differentiation of the vertebrate retina is coordinated by an FGF signaling center
###end article-title 122
###begin article-title 123
Pax6p46 binds chromosomes in the pericentromeric region and induces a mitosis defect when overexpressed
###end article-title 123
###begin article-title 124
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Pax6 regulation of Math5 during mouse retinal neurogenesis
###end article-title 124
###begin article-title 125
Effects of homeobox genes on the differentiation of photoreceptor and nonphotoreceptor neurons
###end article-title 125
###begin article-title 126
###xml 52 57 <span type="species:ncbi:9031">chick</span>
A series of normal stages in the development of the chick embryo
###end article-title 126
###begin article-title 127
Efficient selection for high-expression transfectants with a novel eukaryotic vector
###end article-title 127
###begin article-title 128
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells
###end article-title 128
###begin article-title 129
VEGF activates divergent intracellular signaling components to regulate retinal progenitor cell proliferation and neuronal differentiation
###end article-title 129
###begin article-title 130
Regulation of retinal ganglion cell production by Sonic hedgehog
###end article-title 130

